Hepatitis C treatment update
- 1 September 2004
- journal article
- review article
- Published by Elsevier in The American Journal of Medicine
- Vol. 117 (5) , 344-352
Abstract
No abstract availableKeywords
This publication has 76 references indexed in Scilit:
- 314 A pilot study of a novel anti-inflammatory and anti-fibrotic agent, pirfenidone, in patients with liver cirrhosisHepatology, 2003
- Pirfenidone effectively reverses experimental liver fibrosisJournal of Hepatology, 2002
- Developments in the treatment of chronic hepatitis CExpert Opinion on Investigational Drugs, 2002
- Treatment of Acute Hepatitis C with Interferon Alfa-2bNew England Journal of Medicine, 2001
- Broad-Spectrum Antiviral Activity of the IMP Dehydrogenase Inhibitor VX-497: a Comparison with Ribavirin and Demonstration of Antiviral Additivity with Alpha InterferonAntimicrobial Agents and Chemotherapy, 2000
- The Prevalence of Hepatitis C Virus Infection in the United States, 1988 through 1994New England Journal of Medicine, 1999
- Human immunodeficiency virus infection modified the natural history of chronic parenterally-acquired hepatitis C with an unusually rapid progression to cirrhosisJournal of Hepatology, 1997
- Variability of hepatitis C virusHepatology, 1995
- A randomized controlled trial of recombinant interferon α-2b in the treatment of Chinese patients with acute post-transfusion hepatitis CJournal of Hepatology, 1994
- Treatment of Chronic Non-A, Non-B Hepatitis with Recombinant Human Alpha InterferonNew England Journal of Medicine, 1986